The relationship between sarcoidosis and cognitive difficulties: Effects on mental function and the occurrence of “brain fog”

Introduction

Sarcoidosis is a systemic inflammatory disease of unknown cause, characterised by the formation of immunologically active granulomas in various organs. Although it most commonly affects the lungs and lymph nodes, sarcoidosis can involve multiple systems and cause a range of nonspecific symptoms, including fatigue, pain and neurocognitive difficulties. One frequently reported but insufficiently recognised symptom is so-called brain fog: a subjective feeling of cognitive clouding, with difficulties in concentration, memory and mental clarity.

 

1. Neurological manifestations of sarcoidosis

Neurosarcoidosis

In around 5–15% of patients diagnosed with sarcoidosis, the central or peripheral nervous system is affected, a condition known as neurosarcoidosis. Depending on the location of the granulomatous inflammation, symptoms may include:

difficulty concentrating and processing information,

short-term memory loss,

confusion and personality changes,

depression and anxiety.

Inflammation of brain structures, particularly the frontal lobes or limbic system, can directly impair cognitive function and lead to pronounced brain fog.

---

 

2. The role of systemic inflammation and cytokines

Regardless of direct involvement of the brain, sarcoidosis is associated with chronic activation of the immune system and elevated levels of pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-6. These cytokines can have neurotoxic effects, including:

reduced synaptic plasticity,

changes in the neurotransmitter system,

impaired neurogenesis in the hippocampus.

These changes can cause symptoms similar to those of depression, mild cognitive impairment (MCI) and the so-called “chemobrain” syndrome known in oncology.

---

3. Fatigue, pain and sleep disorders as indirect factors

Many patients with sarcoidosis describe chronic fatigue as their most prominent and hardest-to-tolerate symptom. Fatigue is often associated with:

sleep disturbances, including insomnia, restless legs syndrome and unrefreshing sleep,

chronic pain, for example due to neurosarcoidosis or musculoskeletal changes,

psychological strain, such as anxiety, depression and uncertainty about the outcome of the disease.

All of these can indirectly affect brain function, leading to a subjective feeling of a “clouded mind” and mental exhaustion.

---

4. The effect of treatment on cognition

Standard treatment for sarcoidosis includes corticosteroids, particularly prednisone, which can also have cognitive side effects. High doses of steroids can cause:

problems with attention and short-term memory,

mood changes,

irritability and insomnia.

Immunosuppressants such as methotrexate or biological medicines (anti-TNF) can also have neuropsychiatric effects, although less commonly.

---

5. Clinical practice and diagnostic challenges

Because of the subjective nature of brain fog and the lack of specific biomarkers, this symptom often remains undiagnosed. The following approach is recommended:

Neurological evaluation and brain MRI if neurosarcoidosis is suspected.

Neuropsychological testing for pronounced cognitive difficulties.

Assessment of fatigue, sleep quality and the presence of depression.

Re-evaluation of treatment and its side effects.

---

 

Conclusion

Although brain fog is not pathognomonic for sarcoidosis, its presence can significantly impair patients’ quality of life. Its association with neurological, immunological and psychological mechanisms calls for a multidisciplinary approach to diagnosis and treatment. Further research is needed to better understand the prevalence, pathophysiology and treatment options for managing this complex symptom in people with sarcoidosis.

---

 

Scientific literature

1. Priors, L., et al. (2020). Neurosarcoidosis: A clinical overview and therapeutic update. Frontiers in Neurology, 11: 828. https://doi.org/10.3389/fneur.2020.00828

2. Miller, A., Brown, E. S. (2007). The cognitive effects of corticosteroids: A review. Journal of Clinical Psychiatry, 68(9), 1304–1310.

3. Baughman, R. P., et al. (2017). Fatigue in sarcoidosis: Assessment and treatment. Current Opinion in Pulmonary Medicine, 23(5), 487–495.

4. Kumar, R., et al. (2012). Inflammation and brain function: The role of cytokines in affective disorders. Frontiers in Neuroscience, 6: 30. https://doi.org/10.3389/fnins.2012.00030

5. Lower, E. E., et al. (2014). Neuroc

ognitive functioning in patients with sarcoidosis. Chest, 145(3), 575–582. https://doi.org/10.1378/chest.13-1105